Carlos Alberto Aguilar Salinas

Dr. Carlos Alberto Aguilar Salinas is a Surgeon from the National Autonomous University of Mexico (1980-1986), a specialist in Internal Medicine (1986-1989) and Endocrinology (1989-1991) from the National Institute of Medical Sciences and Nutrition (INCMNSZ). ) and a Doctor in Medical Research from the National Polytechnic Institute. He carried out a research stay (1992-1994) at Washington University, School of Medicine (St Louis MO, USA) on the study of lipoprotein metabolism, under the guidance of Dr. Gustav Schonfeld, founder of the first “Lipid Clinic”. " in the United States. He was a visiting professor at the same institution in 2000. During these years, his work provided insights into the mechanisms that explain plasma cholesterol levels in patients with mutations in the apolipoprotein B gene, in nephrotic syndrome, and in familial combined hyperlipidemia. He is a level F researcher at the National Institutes of Health since 2005 and a member of the National System of Researchers level III since 2008. From 1996 to 2017 he served as deputy head of the Department of Endocrinology and Metabolism of the INCMNSZ and as of 2017, he is the Founding Director of the Institute's own Metabolic Diseases Research Unit. The central axis of his career has been clinical research in metabolic diseases of national importance such as diabetes mellitus and dyslipidemia. He has published more than 320 articles in indexed journals and has received 12,787 citations, index He is a level F researcher at the National Institutes of Health since 2005 and a member of the National System of Researchers level III since 2008. From 1996 to 2017 he served as deputy head of the Department of Endocrinology and Metabolism of the INCMNSZ and as of 2017, he is the Founding Director of the Institute's own Metabolic Diseases Research Unit. The central axis of his career has been clinical research in metabolic diseases of national importance such as diabetes mellitus and dyslipidemia. He has published more than 320 articles in indexed journals and has received 12,787 citations, index He is a level F researcher at the National Institutes of Health since 2005 and a member of the National System of Researchers level III since 2008. From 1996 to 2017 he served as deputy head of the Department of Endocrinology and Metabolism of the INCMNSZ and as of 2017, he is the Founding Director of the Institute's own Metabolic Diseases Research Unit. The central axis of his career has been clinical research in metabolic diseases of national importance such as diabetes mellitus and dyslipidemia. He has published more than 320 articles in indexed journals and has received 12,787 citations, index He is the Director-Founder of the Institute's Metabolic Diseases Research Unit. The central axis of his career has been clinical research in metabolic diseases of national importance such as diabetes mellitus and dyslipidemia. He has published more than 320 articles in indexed journals and has received 12,787 citations, index He is the Director-Founder of the Institute's Metabolic Diseases Research Unit. The central axis of his career has been clinical research in metabolic diseases of national importance such as diabetes mellitus and dyslipidemia. He has published more than 320 articles in indexed journals and has received 12,787 citations, for an index of 62.